Regulatory and Case Analysis of Long-Term Follow-Up for Advanced Therapy Medicinal Products Based on the European Medicines Agency Post-Authorisation Safety Study
Journal of Pharmacoepidemiology and Risk Management · 31.03.2026 · 18 (1) · 29-38
DOI: 10.56142/perm.26.0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, erschienen am 31.03.2026. Verfasst von Jiu Kim und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Institute of Drug Safety and Risk Management.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Korea Institute of Drug Safety and Risk Management
Zitieren
APA
Kim, J., Na, E., Hwang, S., Kim, M., Kim, W. J., Seo, H., Choe, Y., Lim, M. J., & Shin, J. (2026). Regulatory and Case Analysis of Long-Term Follow-Up for Advanced Therapy Medicinal Products Based on the European Medicines Agency Post-Authorisation Safety Study. Journal of Pharmacoepidemiology and Risk Management, 18(1), 29-38. https://doi.org/10.56142/perm.26.0005
Vancouver
Kim J, Na E, Hwang S, Kim M, Kim WJ, Seo H, et al. Regulatory and Case Analysis of Long-Term Follow-Up for Advanced Therapy Medicinal Products Based on the European Medicines Agency Post-Authorisation Safety Study. Journal of Pharmacoepidemiology and Risk Management. 2026;18(1):29-38. doi:10.56142/perm.26.0005
BibTeX
@article{Kim2026,
author = {Kim, Jiu and Na, Eunby and Hwang, Seonghoon and Kim, Minsoo and Kim, Woo Jung and Seo, Hee-Jin and Choe, Yunju and Lim, Min Jeong and Shin, Ju-Young},
title = {Regulatory and Case Analysis of Long-Term Follow-Up for Advanced Therapy Medicinal Products Based on the European Medicines Agency Post-Authorisation Safety Study},
journal = {Journal of Pharmacoepidemiology and Risk Management},
year = {2026},
volume = {18},
number = {1},
pages = {29--38},
doi = {10.56142/perm.26.0005}
}
EUVIMED